Goldman Sachs Raises CPHD Target From $30 To $32
Goldman Sachs is raising its PT on shares of Cepheid (NASDAQ: CPHD) from $30 to $32.
Cepheid closed Wednesday at $28.75.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: cepheid Goldman SachsPrice Target Analyst Ratings